These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26770073)

  • 21. Impaired fibrinolysis in critically ill COVID-19 patients.
    Bachler M; Bösch J; Stürzel DP; Hell T; Giebl A; Ströhle M; Klein SJ; Schäfer V; Lehner GF; Joannidis M; Thomé C; Fries D
    Br J Anaesth; 2021 Mar; 126(3):590-598. PubMed ID: 33422287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of colloid and crystalloid solutions on endogenous activation of fibrinolysis and resistance of polymerized fibrin to recombinant tissue plasminogen activator added ex vivo.
    Mittermayr M; Streif W; Haas T; Fries D; Velik-Salchner C; Klingler A; Innerhofer P
    Br J Anaesth; 2008 Mar; 100(3):307-14. PubMed ID: 18158312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The S100A10 Pathway Mediates an Occult Hyperfibrinolytic Subtype in Trauma Patients.
    Gall LS; Vulliamy P; Gillespie S; Jones TF; Pierre RSJ; Breukers SE; Gaarder C; Juffermans NP; Maegele M; Stensballe J; Johansson PI; Davenport RA; Brohi K;
    Ann Surg; 2019 Jun; 269(6):1184-1191. PubMed ID: 31082919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonactivated thromboelastometry able to detect fibrinolysis in contrast to activated methods (EXTEM, INTEM) in a bleeding patient.
    Durila M
    Blood Coagul Fibrinolysis; 2016 Oct; 27(7):828-830. PubMed ID: 26656899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro inhibition of factor XIII retards clot formation, reduces clot firmness, and increases fibrinolytic effects in whole blood.
    Jámbor C; Reul V; Schnider TW; Degiacomi P; Metzner H; Korte WC
    Anesth Analg; 2009 Oct; 109(4):1023-8. PubMed ID: 19762725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study of tissue factor and kaolin on blood coagulation assays using rotational thromboelastometry and thromboelastography.
    Peng HT; Grodecki R; Rizoli S; Shek PN
    Blood Coagul Fibrinolysis; 2016 Jan; 27(1):31-41. PubMed ID: 26340454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of fibrinolytic status in whole blood using a dielectric coagulometry microsensor.
    Pourang S; Sekhon UDS; Disharoon D; Ahuja SP; Suster MA; Sen Gupta A; Mohseni P
    Biosens Bioelectron; 2022 Aug; 210():114299. PubMed ID: 35533507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole blood rotation thromboelastometry (ROTEM®) profiles in subjects with non-neoplastic portal vein thrombosis.
    Rossetto V; Spiezia L; Senzolo M; Rodriguez-Castro KI; Maggiolo S; Simioni P
    Thromb Res; 2013 Aug; 132(2):e131-4. PubMed ID: 23810655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced fibrinolysis detection in a natural occurring canine model with intracavitary effusions: Comparison and degree of agreement between thromboelastometry and FDPs, D-dimer and fibrinogen concentrations.
    Zoia A; Drigo M; Piek CJ; Calcini H; Caldin M; Simioni P
    PLoS One; 2019; 14(11):e0225089. PubMed ID: 31725761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in fibrinolysis and severity of organ failure in sepsis: a prospective observational study using point-of-care test--ROTEM.
    Prakash S; Verghese S; Roxby D; Dixon D; Bihari S; Bersten A
    J Crit Care; 2015 Apr; 30(2):264-70. PubMed ID: 25454072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of Functional Fibrinolysis in Cord Blood Using Modified Thromboelastography.
    Sidlik R; Strauss T; Morag I; Shenkman B; Tamarin I; Lubetsky A; Livnat T; Kenet G
    Pediatr Blood Cancer; 2016 May; 63(5):839-43. PubMed ID: 26749087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Viscoelastic hemostatic fibrinogen assays detect fibrinolysis early.
    Harr JN; Moore EE; Chin TL; Chapman MP; Ghasabyan A; Stringham JR; Banerjee A; Silliman CC
    Eur J Trauma Emerg Surg; 2015 Feb; 41(1):49-56. PubMed ID: 26038165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The in vivo effect of fibrinogen and factor XIII on clot formation and fibrinolysis in Glanzmann's thrombasthenia.
    Shenkman B; Livnat T; Misgav M; Budnik I; Einav Y; Martinowitz U
    Platelets; 2012; 23(8):604-10. PubMed ID: 22273510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemostasis and fibrinolysis in COVID-19 survivors 6 months after intensive care unit discharge.
    Hulshof AM; Braeken DCW; Ghossein-Doha C; van Santen S; Sels JEM; Kuiper GJAJM; van der Horst ICC; Ten Cate H; van Bussel BCT; Olie RH; Henskens YMC
    Res Pract Thromb Haemost; 2021 Aug; 5(6):e12579. PubMed ID: 34595368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing coagulopathy and endothelial dysfunction in pediatric venous malformation: A thromboelastometry and syndecan-1 study.
    Nava Y Hurtado F; Monzon Manzano E; Viana-Huete V; Triana Junco P; Alvarez-Roman MT; Arias-Salgado EG; Butta N; Lopez Gutierrez JC
    Pediatr Blood Cancer; 2024 May; 71(5):e30915. PubMed ID: 38369689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification of Fibrinolysis Using Velocity Curves Measured with Thromboelastometry in Children with Congenital Heart Disease.
    Faraoni D; Van der Linden P; Ducloy-Bouthors AS; Goobie SM; DiNardo JA; Nielsen VG
    Anesth Analg; 2015 Aug; 121(2):486-91. PubMed ID: 26049780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma tissue-type plasminogen activator increases fibrinolytic activity of exogenous urokinase-type plasminogen activator.
    Shenkman B; Livnat T; Budnik I; Tamarin I; Einav Y; Martinowitz U
    Blood Coagul Fibrinolysis; 2012 Dec; 23(8):729-33. PubMed ID: 22918041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modified ROTEM for the detection of rivaroxaban and apixaban anticoagulant activity in whole blood: A diagnostic test study.
    Pailleret C; Jourdi G; Siguret V; Gouin-Thibault I; Gandrille S; Stepanian A; Curis E; Golmard JL; Gaussem P; Le Bonniec B; Samama CM
    Eur J Anaesthesiol; 2019 Jun; 36(6):449-456. PubMed ID: 30308522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasmin-mediated fibrinolysis by variant recombinant tissue plasminogen activators.
    Urano S; Metzger AR; Castellino FJ
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2568-71. PubMed ID: 2523073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypercoagulation following brain death cannot be reversed by the neutralization of systemic tissue factor.
    Hvas CL; Fenger-Eriksen C; Høyer S; Sørensen B; Tønnesen E
    Thromb Res; 2013 Aug; 132(2):300-6. PubMed ID: 23910501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.